In addition, signal transduction pathway analysis using the INOH database revealed significant enrichment of the JAK1 and JAK2 pathways, both which are critical upstream kinases that activate STAT3 through phosphorylation, in CH patients (Fig. 7D). The gene discussed is JAK2; the disease is cyclic hematopoiesis.